Skip to main content
Compass Pathways: home
  • About us
        • About us

          Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

        • About us
          • Our purpose
          • Our stories
          • Our values
          • Our approach
        • Our team
          • Executive Team
          • Board of Directors
        • Our stories

          Everyone has a story about how mental health has affected them or someone they know. Our people bring their stories, and a wide range of backgrounds and skills, to Compass.

          Read our stories
  • Our work
        • Our work

          We want to give people living with mental health challenges better options.

        • About psilocybin therapy
        • Pipeline
          • Treatment-resistant depression (TRD)
          • Post-traumatic stress disorder (PTSD)
          • Anorexia nervosa
          • Pipeline overview
          • Investigator-initiated studies
        • Therapist training
        • Preclinical research
          • Discovery Center
        • Digital technologies
          • Digital technology blog
        • Our publications and results
          • COMP360 psilocybin in healthy participants
          • COMP360 psilocybin treatment in TRD
          • COMP360 psilocybin treatment in TRD with antidepressants
          • Therapist training: Frontiers in Psychiatry
        • Partnerships and collaborations
          • Centres of Excellence
          • Partnerships
        • Our approach
          • Compassionate use policy
          • Animal welfare
        • phase II clinical trial of psilocybin therapy
        • Our blog

          Read our blog to learn more about Compass and our work.

          Read more
  • Join us
        • Join us

          We are united by our commitment to improving mental health.

        • Join us
          • Our culture
          • Benefits
          • Careers
          • 60 seconds with ...
        • Our purpose

          Watch our purpose video to find out who we are and what defines us.

          Find out more about our purpose
  • News and views
        • News and views

          Our collective understanding of mental illness is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

        • Press releases
        • Our blog
        • Compass
        • Our blog

          Read our blog to learn more about Compass and our work.

          Read more
  • Investors
        • Investors

          We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

        • News & events
          • News
          • Events & presentations
          • Our annual review
        • Financials
          • SEC filings
          • Annual reports
          • PFIC annual information statements
        • Stock info
          • Stock quote
          • Analyst Coverage
          • Split history
        • Governance
          • Documents & charters
          • Executive Team
          • Board of directors
          • Committee composition
          • Annual general meeting
        • Resources
          • FAQs
          • Shareholder privacy notice
          • Email alerts
          • IR contacts
        • COMP360 psilocybin treatment in TRD

          We have completed the largest randomised, controlled, double-blind psilocybin treatment study ever done.

          Read more about COMP360 psilocybin treatment in TRD
  • LinkedIn
  • Youtube
  • Twitter
  • Accessibility
accessibility options
  • High Contrast
  • Greyscale
  • Negative Contrast
  • Readable
  • Reset
Contact us

Articles

Read our latest news and updates.

For media inquiries, contact us at media@compasspathways.com

  • Compass’s hiking club
    July 31, 2024

    Compass’s hiking club

    Read article

  • Lori quote card
    July 08, 2024

    Joining a mission-driven team: talking to Lori Englebert, Compass’s new Chief Commercial Officer

    Read article

  • Recognising Quality at Compass
    May 20, 2024

    Recognising Quality at Compass

    Read article

  • Mike blog
    May 20, 2024

    Celebrating Clinical Trials Day with Mike Gold, Compass’s new Chief Research & Development Of...

    Read article

  • Laptop
    May 16, 2024

    Advancing Digital Accessibility

    Read article

  • Anne B new photo
    May 14, 2024

    Supporting our team’s wellbeing

    Read article

  • Recognising and celebrating neurodiversity
    March 18, 2024

    Recognising and celebrating neurodiversity

    Read article

  • Jarell Bempong
    February 28, 2024

    Exploring cultural consciousness with Jarell Bempong

    Read article

  • Pride month
    June 01, 2023

    Celebrating Pride 2023

    Read article

  • Hina Dubin Quote
    April 06, 2023

    Talking to a Principal Investigator on our Phase 3 programme

    Read article

  • Launching our Diversity Equity and Inclusion (DEI) council
    March 08, 2023

    Launching our Diversity Equity and Inclusion (DEI) council

    Read article

  • Compass’s impact strategy
    February 16, 2023

    Compass’s impact strategy

    Read article

  • Celebrating the International Day of Women and Girls in Science
    February 10, 2023

    Celebrating the International Day of Women and Girls in Science

    Read article

  • Esmeralda and her two children
    January 25, 2023

    Supporting parents at work

    Read article

  • Holiday traditions
    December 15, 2022

    Our holiday traditions and reflections

    Read article

  • Maya playing Horseball
    December 01, 2022

    Pursuing passions: on playing Horseball for Great Britain

    Read article

  • World Quality Week at Compass
    November 09, 2022

    Celebrating World Quality Week at Compass

    Read article

  • diversity equity and inclusion panel
    October 26, 2022

    Diversity, equity and inclusion in our therapist training programme

    Read article

  • Dee Shore
    October 10, 2022

    What it’s like to live with treatment-resistant depression

    Read article

  • Dr Shahid Hanif quote
    September 29, 2022

    GetReal Institute: the importance of real world evidence

    Read article

  • Rachel Yehuda quote card
    August 18, 2022

    The investigators leading our research in post-traumatic stress disorder

    Read article

  • Kabir with George and Katya
    July 19, 2022

    Letter from Kabir Nath, our new CEO from August 1, 2022

    Read article

  • Photo of Molly Hickey
    July 18, 2022

    Our green mission: reusing our office technology

    Read article

  • Rachel Bellamy, Senior Corporate Development Associate
    July 06, 2022

    Our Mental Health Experiences community

    Read article

  • Nadav Liam Modlin
    June 28, 2022

    Psychological therapist Nadav Liam Modlin talks about PTSD

    Read article

  • Pushkar Joshi at One Mind
    May 25, 2022

    Accelerating mental health research in collaboration with One Mind

    Read article

  • Ozlem Redjep, Manager of Clinical Project Coordination
    May 20, 2022

    Coordinating clinical trials: a day in the life

    Read article

  • Leora, Community Wellbeing Lead
    May 10, 2022

    Talking to Leora, our Community Wellbeing Lead

    Read article

  • Photo of our Compass green team
    March 31, 2022

    Our green website

    Read article

  • steven l
    March 22, 2022

    One year on from the launch of our charters

    Read article

1 2 Next »
  1. Home
  2. Articles
This website runs on green hosting - verified by thegreenwebfoundation.org

This website is powered by renewable energy

Useful links
  • Contact us
  • About psilocybin therapy
  • About us
  • Join us
  • News and views
Follow us
  • LinkedIn
  • Youtube
  • Twitter
Sign up

Subscribe to receive the latest Compass news.

Subscribe
  • Unsolicited Information Policy
  • Terms
  • Privacy
  • myPathfinder privacy

Compass © 2025. All rights reserved. Made by GIG.

The press releases and articles contained in this section are provided for historical purposes only. The information contained in each press release and article is accurate only as of the date each press release and article was originally issued. Compass disavows any obligation to update the information contained in such press releases and articles after the date of their issuance.

You are now leaving Compass Pathways’ website.

Compass does not control and is not responsible for the content on the website you are about to visit. Compass is providing this link as a convenience, and this link does not imply Compass endorsement of any material on the website you are about to visit. Do you wish to continue?